Thanks to our world-class researchers, state-of-the-art technologies and unrelenting focus on scientific excellence, Merck is at the forefront of discovering and developing innovative ways to treat and prevent disease.
Scientific innovation has always been the cornerstone of our company and that continues today. Today, we conduct research in a broad range of therapeutic categories – including cardiovascular, diabetes and endocrinology, neurosciences and ophthalmology, oncology, infectious diseases, and respiratory and immunology.
Here in Puerto Rico, we manifest our commitment to innovation in science every day. Through nearly 250 early-phase clinical trials, in more than 50 clinical centers, we have brought the latest advances in medicine to thousands of Puerto Rican patients. We are also proud to contribute local epidemiological and demographic data in partnership with the Puerto Rico medical community, scientific and academic institutions.